Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®

Authors not listed

Allergan · 2014

Abstract

This study will use retrospective data to evaluate the safety and efficacy of OZURDEX® (dexamethasone intravitreal implant 0.7 mg) in the treatment of macular oedema due to retinal vein occlusion (RVO) in clinical practice. No intervention will be administered as part of this study.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-08 MST

Cite this

APA
Anonymous. (2014). Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®. <em>Allergan</em>. https://clinicaltrials.gov/study/NCT02181530
Vancouver
Anonymous. Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®. Allergan. 2014.
BibTeX
@misc{anon2014Retros, title = {Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®}, author = {Anonymous}, journal = {Allergan}, year = {2014}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings